Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Johnson

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Nature Medicine|April 15, 2020
Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activationErik C B Johnson, Eric B Dammer, Duc M Duong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADSDustin B Hammers, Ani Eloyan, Alexander Taurone, et al.
Alzheimer'S Research & Therapy|February 6, 2025
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approachDeepti Putcha, Yuta Katsumi, Alexandra Touroutoglou, et al.
The Journal of Prevention of Alzheimer'S Disease|February 16, 2025
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trialsDustin B Hammers, Jane Musema, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNIDustin B Hammers, Ani Eloyan, Maryanne Thangarajah, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 30, 2026
Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNIDustin B Hammers, Ani Eloyan, Maryanne Thangarajah, et al.
Cell|September 27, 2024
CSF proteomics identifies early changes in autosomal dominant Alzheimer's diseaseYuanyuan Shen, Jigyasha Timsina, Gyujin Heo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2026
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADSDustin B Hammers, Elodie Foster, Ani Eloyan, et al.
Cell|March 24, 2026
Pan-neurodegeneration proteomics reveals disease subtypes and molecular signaturesHim K Shrestha, Huan Sun, Jay M Yarbro, et al.
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Nature Medicine|April 15, 2020
Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activationErik C B Johnson, Eric B Dammer, Duc M Duong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADSDustin B Hammers, Ani Eloyan, Alexander Taurone, et al.
Alzheimer'S Research & Therapy|February 6, 2025
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approachDeepti Putcha, Yuta Katsumi, Alexandra Touroutoglou, et al.
The Journal of Prevention of Alzheimer'S Disease|February 16, 2025
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trialsDustin B Hammers, Jane Musema, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNIDustin B Hammers, Ani Eloyan, Maryanne Thangarajah, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 30, 2026
Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNIDustin B Hammers, Ani Eloyan, Maryanne Thangarajah, et al.
Cell|September 27, 2024
CSF proteomics identifies early changes in autosomal dominant Alzheimer's diseaseYuanyuan Shen, Jigyasha Timsina, Gyujin Heo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2026
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADSDustin B Hammers, Elodie Foster, Ani Eloyan, et al.
Cell|March 24, 2026
Pan-neurodegeneration proteomics reveals disease subtypes and molecular signaturesHim K Shrestha, Huan Sun, Jay M Yarbro, et al.
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Pageof 21